SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

Historical Holders from Q4 2023 to Q2 2025

Symbol
SABS on Nasdaq
CUSIP
78397T202
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
260M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
1.92M
Holdings value
$3.37M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
25
Number of buys
9
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 9.99% $55M 25.9M Vivo Opportunity Fund Holdings, L.P. Sep 29, 2025
Commodore Capital LP 9.9% $9.59M 4.52M Commodore Capital LP Sep 26, 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $9.33M 4.4M RA Capital Management, L.P. Sep 26, 2025
RTW INVESTMENTS, LP 9.99% $1.31M 1.02M RTW Investments, LP Dec 31, 2024

Institutional Holders of SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 1.92M $3.37M -$379K $1.76 25
2025 Q1 2.21M $2.99M -$1.78M $1.36 26
2024 Q4 2.63M $10.1M -$1.28M $3.80 25
2024 Q3 3.14M $8.48M +$68.5K $2.70 24
2024 Q2 3.13M $9.69M -$924K $3.10 21
2024 Q1 3.34M $15.2M -$15.6M $4.54 23
2023 Q4 8.79M $6.06M +$6.06M $0.69 3